{
    "2020-12-08": [
        [
            {
                "time": "",
                "original_text": "白酒股太疯狂！19年涨396倍的茅台只能排第二",
                "features": {
                    "keywords": [
                        "白酒",
                        "茅台",
                        "涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品饮料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "京东健康在港上市首日一度大涨73% 上市公司抢食互联网医疗",
                "features": {
                    "keywords": [
                        "京东健康",
                        "上市",
                        "互联网医疗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "红塔证券又一股东计划减持：拟减持不超过1100万股、另一股东已减持3747万股今年多次违规、6月份亏损近亿元、近四个多月股价下跌三成\n金融监管处罚",
                "features": {
                    "keywords": [
                        "红塔证券",
                        "减持",
                        "违规",
                        "亏损",
                        "股价下跌",
                        "金融监管"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020年12月投资月报：医药反弹持续性如何？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资月报",
                        "反弹持续性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药反弹持续性如何？——兴证医药2020年12月投资月报",
                "features": {
                    "keywords": [
                        "医药反弹",
                        "持续性",
                        "兴证医药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：从批签发变化来看血制品行业有望迎来高景气度，维持“强于大市”评级",
                "features": {
                    "keywords": [
                        "医药生物",
                        "批签发",
                        "血制品",
                        "高景气度",
                        "强于大市"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2021年股市、经济、全产业投资策略来了！请收藏锦囊（续）",
                "features": {
                    "keywords": [
                        "2021年",
                        "股市",
                        "经济",
                        "投资策略"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}